Menu
1-702-720-6310 info@microcapspecualtors.com

Major Movers in Cannabis and Biotech

Yesterday was a really strong day for several exciting companies in cannabis and biotech.  With lots of enthusiasm in the market, there is no telling how quickly one of these firms could make another move major move higher.  

A small biotechnology company that we have discovered is ENDV (Endonovo Therapeutics, Inc.). ENDV closed up 52% yesterday, and appears to be moving upward like a freight train.  ENDV is starting to receive significantly increased attention from the street, and if this is your first-time hearing about ENDV start doing your own research immediately.  ENDV is a very exciting company that has an FDA-Cleared Electroceutical™ System, SofPulse®, for the palliative treatment of post-operative pain and edema in superficial soft tissues.  Additionally, ENDV recently signed a national distribution agreement for sales, marketing and distribution of SofPulse® targeting the VA, DOD, Indian Health Services, Long Term Care Institutions, Pain Clinics, Wound Clinics and Private Practices among physicians.which is a very positive development.  Those that find ENDV before the rest of the crowd could be in store for a great run.  

These cannabis and biotech companies are on the rise and should be on everyone’s watchlist: Endonovo Therapeutics, Inc. (OTCQB: ENDV), CV Sciences, Inc. (CVSI), Canopy Growth Corporation (CGC) and Aurora Cannabis (ACBFF)

Endonovo Therapeutics, Inc. (OTCQB: ENDV)

Market Cap: $13.91M, current share price: $0.038

Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical™ Therapy.. The Company’s current portfolio of commercial and clinical-stage wearable Electroceuticals™ Therapies addresses wound healing, pain, post-surgical pain and edema, cardiovascular disease, chronic kidney disease, and Central Nervous System (CNS) Disorders, including traumatic brain injury (TBI), acute concussions, post-concussion syndrome and multiple sclerosis. The Company’s non-invasive Electroceutical™ System device, SofPulse®, using pulsed short-wave radiofrequency at 27.12 MHz has been FDA-Cleared and CE Marked for the palliative treatment of soft tissue injuries and post-operative pain and edema, and has CMS National Coverage for the treatment of chronic wounds. The Company’s current portfolio of pre-clinical stage Electroceuticals™ addresses chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke. The Company’s non-invasive, wearable Electroceuticals™ work by restoring key electrochemical processes that initiate anti-inflammatory and growth factor cascades necessary for healing to occur.

 

CV Sciences, Inc. (CVSI)

Market Cap: $447.9M Share Price: $4.94

CV Sciences (CVSI) has received more positive attention after it announced that it had appointed Joseph Maroon, MD, FACS to its Board of Directors. The Nevada-based company operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD, and a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors.

Canopy Growth Corporation (CGC)

Market Cap: $10.21B Share Price: $46.32

Constellation Brands announced a partnership with Canopy Growth back in October.  Investors benefited recently from the partnership as Constellation Brands pledged an additional $4 billion to their stake in the company.  This week through its wholly-owned subsidiary Tweed Inc., has been selected as an approved supplier by the Ontario Cannabis Store (“OCS”) to supply a wide variety of cannabis products through its online store starting October 17th, 2018 .

Aurora Cannabis (ACBFF)

Market Cap: $6.74B Share Price: $7.10

Aurora Cannabis is receiving investor attention after announcing that its acquisition of Anandia Laboratories Inc. (“Anandia”) is now complete. The previously announced arrangement, under the provisions of the Business Corporations Act ( British Columbia ), means that among other things, Aurora has now acquired all of the issued and outstanding shares of Anandia in an all-share transaction (the “Transaction”).

Anandia is a world-leading cannabis-focused science company, specialized in genomics, metabolite profiling, plant breeding, disease characterization, and cultivar certification, as well as providing testing services to producers and patient-cultivators.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two.  ACR Communication, LLC has been compensated one thousand dollars cash for this article and sixty six thousand dollars total by Regal Consulting. LLC, for news commentary articles for ENDV.  ENDV and Regal Consulting, LLC were given an opportunity to edit information included in this article.  This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information.  ACR Communication, LLC, will not buy or sell any shares in stocks contained within this article for forty eight hours after this article’s distribution.

For Full Legal Disclaimer Click Here.

Contact Information:

Company Name: Microcap Speculators

Contact Person: Media Manager

Email: info@microcapspecualtors.com

Phone: 1-702-720-6310

Country: United States

Website: http://microcapspeculators.com/

Search